Risk factor
Poor trading liquidity
Profitability factor
Very favourable analyst view
About
Ever Fortune.AI Co., Ltd. provides artificial intelligence cloud services. It offers bone age assessment system that assists doctors in bone age assessment and predicting a child's final height; and breast ultrasound tumor classification system, which assists doctors in the diagnosis of the tumor, non-invasive screening of breast puncture, and biopsy to determine the malignancy of the breast tumor. The company also provides computer tomography liver cancer metastatic risk assessment system that enhances the radiologist's efficiency and assesses the metastatic risk of liver cancer; liver fibrosis assessment system to assess liver fibrosis; and an atrial fibrillation detection system that interprets the electrocardiogram signal and assesses the condition of the heart. Ever Fortune.AI Co., Ltd. is based in Taichung City, Taiwan. Ever Fortune.AI Co., Ltd operates as a subsidiary of An Ji Biomedical Corporation.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBITD.
Target Price
The average target price of 6841.TWO is 108 and suggests 85% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell